Cancer care is one of the most complex and resource-intensive areas of medicine. Patients need specialized support to manage the physical and emotional demands of treatment. Treatment toxicities, comorbidities, and frequent hospital visits strain both patients and care teams. These pressures make timely intervention and continuous monitoring essential. Remote patient monitoring (RPM) in cancer care has become a practical tool to support oncology patients and improve care quality between visits.
The scale of the problem keeps growing. The American Cancer Society projects about 2,114,850 new cancer cases and 626,140 cancer deaths in the United States in 2026. At the same time, five-year survival for all cancers combined has reached 70%, so more people are living longer with cancer and need sustained monitoring. Remote patient monitoring helps close the gap between clinic visits and daily life.
By tracking vital signs such as blood pressure, weight, blood oxygen, blood glucose, and temperature, remote patient monitoring gives providers real-time data to catch complications early and adjust treatment quickly. Unlike traditional cancer care models built around episodic visits, RPM creates a continuous flow of data. Clinicians can act before small issues become emergencies. For patients, remote patient monitoring in cancer care offers reassurance and a more active role in managing their own health.
This article looks at how remote patient monitoring is applied in oncology, the latest evidence behind its use, and the specific benefits across key areas of cancer management.
What the 2025-2026 Evidence Shows on Remote Patient Monitoring in Cancer Care
The evidence base for remote patient monitoring in cancer care has grown quickly, and recent studies are stronger than the early pilots. Several 2025 and 2026 publications point in the same direction: fewer hospitalizations and real cost savings.
A 2025 nonrandomized controlled trial published in JAMA Network Open studied electronic patient-reported outcome (ePRO) remote symptom monitoring across 5,949 cancer patients. Hospitalizations were 19% lower at three months and 13% lower at six months among patients receiving remote symptom monitoring compared with historical controls. The authors concluded the results support expanding remote symptom monitoring nationally.
A 2026 study of community oncology practices reinforced those findings. Researchers followed 1,549 patients with metastatic solid tumors receiving systemic treatment at five community oncology centers between January 2024 and July 2025. Hospitalizations were 9% in the remote therapeutic monitoring (RTM) group versus 13% in the control group, a 28% relative reduction. The team estimated cost savings of roughly $3.19 million per 1,000 patients per year from avoided hospitalizations alone.
A 2025 systematic review in Digital Health examined studies published between 2019 and 2024 and found that remote patient monitoring has the potential to reduce hospitalizations and length of stay among cancer patients through better symptom management and timely intervention. The review noted the evidence still varies in quality, which is why well-designed studies remain important. Taken together, the direction of the research is consistent: remote patient monitoring in cancer care keeps more patients out of the hospital.
How Remote Patient Monitoring Supports Oncology Patients
There are more than 100 types of cancer, so it is no surprise that cancer brings a wide range of causes, symptoms, and co-occurring conditions. Remote patient monitoring changes how patients, caregivers, and providers navigate the complex course of anti-cancer treatment. It supports better cancer management at home between visits, helping clinicians identify high-risk patients and coordinate care before a hospital stay becomes necessary.
Remote monitoring also tracks how patients respond to treatment. With regular health data, clinicians can adjust treatment and medication plans sooner, which improves care quality. Early intervention reduces emergency room visits and hospital admissions.
Care navigation has grown alongside remote monitoring. Principal Illness Navigation (PIN) services, introduced in the CY2024 Medicare Physician Fee Schedule and continued in later rules, let practices support patients with serious conditions like cancer in a more person-centered way. Navigator-supported remote symptom monitoring is now an active area of study, with trials testing how to scale it across diverse patient populations.
Many oncology patients benefit from monitoring more than one vital sign. The specific remote patient monitoring device depends on the cancer type, symptoms, and co-occurring conditions. The sections below explain how monitoring blood pressure, weight, blood glucose, blood oxygen, and temperature supports cancer management.
Blood Pressure Monitoring and Cancer Care
Remote blood pressure monitoring is an effective way to watch treatment effects in cancer patients. A Scientific Reports meta-analysis found positive associations between hypertension and the risk of kidney, colorectal, breast, endometrial, liver, and esophageal cancers. Hypertension is among the most frequently reported comorbidities in cancer patients.
Common treatments such as chemotherapy and anti-vascular endothelial growth factor (VEGF) medications can raise blood pressure. Because of this added risk, regular blood pressure monitoring matters in cancer patients. Managing hypertension well helps patients continue the treatment they need to control tumor growth without further harm to their organs.
Weight Monitoring for Cancer Care With RPM
Unexplained weight loss is a common symptom of cancer. Research suggests the greatest cancer risk occurs within one to three months of unexplained weight loss. About 40% of cancer patients report unexplained weight loss at diagnosis.
Some cancers, particularly breast, prostate, and ovarian, can cause the opposite effect: rapid weight gain. Hormone therapy and anti-cancer medications can make the body retain fluid, leading to bloating. Remote weight monitoring, often used in congestive heart failure, gives useful insight into how cancer patients respond to treatment.
Weight loss of three or more pounds a week, or gain of five or more pounds a week, usually needs medical attention. A remote weight monitoring platform alerts clinicians right away when a patient’s measurement crosses a set threshold. Clinicians can then act quickly and provide care before symptoms progress.
Blood Glucose Monitoring and Cancer Care
Remote blood glucose monitoring is another way to support cancer patients. Many people manage both diabetes and cancer at the same time. Diabetes involves high blood glucose, and cancer cells rapidly metabolize glucose for energy. High glucose levels can give tumors abundant fuel for growth.
Many cancer treatments, including radiation therapy, steroids, and chemotherapy, can raise blood glucose. Patients can better control their levels through diet, exercise, and remote patient monitoring. A wireless blood glucose meter keeps patients accountable for their readings. Patients are more likely to measure regularly when they know a clinician is watching the data. Devices that need no syncing or apps make it easier to keep a consistent schedule.
Blood Oxygen Monitoring and Cancer Care
Patients with lung cancer can benefit from remote blood oxygen monitoring. Dyspnea, or shortness of breath, is a common side effect of lung cancer treatment and the most common symptom across lung cancers. Many patients may not take in enough oxygen to fuel normal body processes.
Hypoxia, a lack of oxygen in the tissues, can change how cancer cells behave and make them resistant to treatment. By monitoring blood oxygen with a wireless pulse oximeter, clinicians can confirm a patient is responding well to treatment or adjust the plan quickly to prevent progression.
Temperature Monitoring for Cancer Care
A remote patient monitoring thermometer helps detect fever, including fever from cytokine release syndrome. In one study, researchers identified fevers nearly five hours earlier than standard hospital checks done every four to eight hours. The study also looked at subtle temperature shifts that signal a change from the patient’s usual circadian pattern. Catching a problem before a significant spike is important, since some complications worsen fast.
Remote Patient Monitoring in Cancer Care: Frequently Asked Questions
1) Does remote patient monitoring reduce hospitalizations for cancer patients?
The recent evidence points that way. A 2025 JAMA Network Open trial found hospitalizations were 19% lower at three months among cancer patients using remote symptom monitoring. A 2026 community oncology study found a 28% relative reduction in hospitalizations with remote therapeutic monitoring.
2) Which vital signs matter most in remote patient monitoring for cancer care?
It depends on the cancer type, treatment, and co-occurring conditions. Blood pressure, weight, blood glucose, blood oxygen, and temperature are the most commonly monitored. Many oncology patients track more than one at a time.
3) Is remote patient monitoring in cancer care cost-effective?
Recent data suggests it can be. A 2026 study of metastatic cancer patients estimated savings of about $3.19 million per 1,000 patients per year from avoided hospitalizations, plus additional savings from fewer emergency department visits.
4) How is remote patient monitoring different from a routine oncology visit?
A routine visit captures a single point in time. Remote patient monitoring adds a continuous stream of data between visits. That data transmits automatically from connected devices, so care teams can spot changes early rather than waiting for the next appointment.
5) Can remote patient monitoring help with cancer symptom management?
Yes. Studies of electronic patient-reported outcome monitoring show that structured symptom tracking helps clinicians respond sooner. Patients often report symptoms at higher severity than clinicians observe in visits, so remote monitoring helps surface problems that might otherwise be missed.
Understanding Remote Patient Monitoring in Cancer Care
Remote patient monitoring lets clinicians observe cancer progression and treatment effects closely, and it moves care beyond the clinic into patients’ everyday lives for steadier, more comfortable monitoring. Patients gain a better understanding of their condition and are more likely to adhere to their treatment plans. The latest 2025 and 2026 studies show that remote patient monitoring in cancer care can lower hospitalizations and generate real cost savings, while helping care teams catch complications before they require a hospital stay. As cancer incidence rises and more patients live longer after diagnosis, continuous monitoring will keep growing in importance.
Tenovi provides the connected-device infrastructure that powers remote patient monitoring programs for oncology-focused care organizations, RPM software companies, and chronic care management providers. Our cellular Gateway and devices transmit patient data automatically, so care teams get reliable readings without relying on patient Wi-Fi, apps, or setup steps. To see how Tenovi can support oncology remote monitoring, contact us for a free demo and consultation.
